Actinium Pharmaceuticals
ATNM
ATNM
26 hedge funds and large institutions have $5.14M invested in Actinium Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
9% less capital invested
Capital invested by funds: $5.65M → $5.14M (-$510K)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Holders
26
Holding in Top 10
–
Calls
$97K
Puts
$7K
Top Buyers
| 1 | +$489K | |
| 2 | +$181K | |
| 3 | +$100K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$48.7K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$18K |
Top Sellers
| 1 | -$119K | |
| 2 | -$100K | |
| 3 | -$23K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$20K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$20K |